## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.6% in lower entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (3.6%) confirms momentum alignment. Strong momentum (+4.1% 5-day acceleration). Outperforming sector by 7.0%. Caution: overbought RSI (76).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($619.18)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Ulta Beauty (ULTA) Valuation Check As Rare Beauty Rollout And Philanthropy Ignite Investor Interest**
- Source: Simply Wall Street | 20260106T202315 | Somewhat-Bullish | Relevance: 100%
- Ulta Beauty (ULTA) is facing a valuation check despite strong recent share price performance and the upcoming rollout of Selena Gomez’s Rare Beauty line, coupled with mental health initiatives. The company's stock is trading near an all-time high and slightly above analyst price targets, prompting questions about remaining upside for investors. While expansion plans aim to attract Gen Z and Millennials and boost margins, potential pressure points like higher costs and the loss of Target shop-in-shop revenue after 2026 could affect future performance.

**2. Is Ulta Beauty Inc Experiencing a Bullish or Bearish Trend in the Market?**
- Source: Bitget | 20260106T201500 | Bullish | Relevance: 100%
- Ulta Beauty Inc (NYSE: ULTA) has seen its short interest decrease by 8.82% to 2.10 million shares, representing 6.2% of its available shares. This decline in short interest suggests growing optimism among investors, as it indicates fewer shares are being bet against. Compared to its peers, Ulta Beauty Inc has a lower short interest, further implying a potentially bullish sentiment for the stock.

**3. Is Ulta Beauty Inc Experiencing a Bullish or Bearish Trend in the Market?**
- Source: Bitget | 20260106T042215 | Somewhat-Bullish | Relevance: 100%
- Short interest in Ulta Beauty Inc (NYSE: ULTA) has decreased by 8.82%, with 2.10 million shares sold short, representing 6.2% of its float. This lower short interest compared to its peer group (average 14.47%) suggests a potentially more optimistic market sentiment for Ulta Beauty. While a drop in short interest doesn't guarantee a price increase, it indicates fewer investors are betting against the stock.

**4. EXCLUSIVE: Rare Beauty to Launch Nationwide at Ulta Beauty**
- Source: WWD | 20260105T130314 | Bullish | Relevance: 100%
- Selena Gomez’s Rare Beauty is set to launch nationwide at Ulta Beauty on February 1, expanding its reach beyond Sephora to over 1,500 stores and ulta.com. This move aims to increase accessibility for the brand, which reported $400 million in sales in 2024 and is valued at over $2 billion. The partnership will also include a guest donation initiative benefiting both the Ulta Beauty Charitable Foundation and the Rare Impact Fund.

**5. What Ulta Beauty (ULTA)'s 'Ulta Beauty Unleashed' Store Revamp Means For Shareholders**
- Source: Simply Wall Street | 20260104T205357 | Neutral | Relevance: 100%
- Ulta Beauty launched "Ulta Beauty Unleashed" to enhance in-store experiences and expand into international markets, aiming to diversify sales and reinforce its physical store model against online rivals. This initiative supports Ulta's strategy of offering experiential shopping and a broader product range, including the new UB Marketplace, while the company faces potential cost inflation and the eventual loss of its Target partnership. The article examines how this revamp could reshape Ulta Beauty’s investment narrative, with projected revenues of $13.8 billion and earnings of $1.3 billion by 2028, but also highlights investor concerns about rising operating costs and varying fair value estimates.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-02 | Argus Research | $700 | $650 | +8% |
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-02 | Argus Research | main | Buy |
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 4 raises (avg +11%) could attract flows.
- Momentum building: MRS_20 improving +4.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.44 elevated, pricing in significant growth expectations. Forward P/E 23.0x stretched relative to 11% growth. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (4 raises, avg +11%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.1B |
| Beta | 0.85 |
| 52W Range | $309.01 - $654.89 |
| Short Interest | 6.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.44 |
| Forward P/E | 23.0 |
| Current P/E | 25.5 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 2.6% to 6.6% (+4.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 3.6% confirms short-term momentum alignment. AM_20 at 7.5% shows strong absolute momentum above own 20MA. Outperforming sector by 7.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.95), confirming momentum. RSI overbought at 76, risk of mean reversion. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.63% (CS: 88) | Strong |
| RSI_14 | 75.5 | Overbought |
| MACD Histogram | 1.95 | Bullish |
| vs SMA20 | 1.075x | Above |
| vs SMA50 | 1.168x | Above |
| vs SMA200 | 1.326x | Above |

### Decision

- **Verdict:** HOLD
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $650.06
- **Stop Loss:** $619.18 (4.8% risk)
- **Target:** $696.38 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 35
- **Position Value:** $22,752.10
- **Portfolio %:** 22.75%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*